| 2024-04 |
Neither hepatic steatosis nor fibrosis is associated with clinical outcomes in patients with intestinal Behçet’s disease |
European Journal of Gastroenterology and Hepatology
|
| 2024-01 |
HBV DNA and HBsAg Levels at 24 Weeks Off-Treatment Predict Clinical Relapse and HBsAg Loss in HBeAg-Negative Patients Who Discontinued Antiviral Therapy |
Gastroenterology
|
| 2023-12 |
Surveillance for hepatocellular carcinoma in non-alcoholic fatty liver disease patients: towards personalized risk stratification |
HEPATOBILIARY SURGERY AND NUTRITION
|
| 2023-11 |
Lactobacillus plantarum ameliorates NASH-related inflammation by upregulating l-arginine production |
Experimental and Molecular Medicine
|
| 2023-11 |
Inhibition of Dickkopf-1 enhances the anti-tumor efficacy of sorafenib via inhibition of the PI3K/Akt and Wnt/β-catenin pathways in hepatocellular carcinoma |
Cell Communication and Signaling
|
| 2023-09 |
MAFLD might be better in identifying subjects with sarcopenia or cardiovascular risk than NAFLD: A nationwide study |
Journal of Gastroenterology and Hepatology
|
| 2023-08 |
Noninvasive risk assessment of hepatic decompensation in patients with hepatitis B virus‐related liver cirrhosis |
Journal of Gastroenterology and Hepatology
|
| 2023-08 |
A machine learning model for predicting hepatocellular carcinoma risk in patients with chronic hepatitis B |
Liver international : official journal of the International Association for the Study of the Liver
|
| 2023-08 |
ALT Is Not Associated With Achieving Subcirrhotic Liver Stiffness and HCC During Entecavir Therapy in HBV-Related Cirrhosis |
Clinical Gastroenterology and Hepatology
|
| 2023-05 |
Hepatic Steatosis but Not Fibrosis Is Independently Associated with Poor Outcomes in Patients with Inflammatory Bowel Disease |
Gut and Liver
|
| 2023-05 |
Lower pretreatment HBV DNA levels are associated with better off-treatment outcomes after nucleo(s)tide analogue withdrawal in patients with HBeAg-neegative chronic hepatitis B: A multicentre cohort study |
JHEP Reports
|
| 2023-05 |
Preventive effect of empagliflozin and ezetimibe on hepatic steatosis in adults and murine models |
Biomedicine and Pharmacotherapy
|
| 2023-04 |
Response-Guided Therapy With Cefotaxime, Ceftriaxone, or Ciprofloxacin for Spontaneous Bacterial Peritonitis: A Randomized Trial A Validation Study of 2021 AASLD Practice Guidance for SBP |
American Journal of Gastroenterology
|
| 2023-03 |
Metabolic dysfunction associated fatty liver disease identifies subjects with cardiovascular risk better than non-alcoholic fatty liver disease |
Liver International
|
| 2023-02 |
Sorafenib versus nivolumab after lenvatinib treatment failure in patients with advanced hepatocellular carcinoma |
European Journal of Gastroenterology and Hepatology
|
| 2023-01 |
The clinical effect of antiviral therapy in patients with hepatitis B virus-related decompensated cirrhosis and undetectable DNA |
Journal of Gastroenterology and Hepatology
|
| 2023-01 |
Suboptimal Performance of Hepatocellular Carcinoma Prediction Models in Patients with Hepatitis B Virus-Related Cirrhosis |
DIAGNOSTICS
|
| 2023-01 |
Integrative analysis of multiple genomic data from intrahepatic cholangiocarcinoma organoids enables tumor subtyping |
Nature Communications
|
| 2022-10 |
Identification of a distinct NK-like hepatic T-cell population activated by NKG2C in a TCR-independent manner |
Journal of Hepatology
|
| 2022-10 |
Applications of molecular barcode sequencing for the detection of low-frequency variants in circulating tumour DNA from hepatocellular carcinoma |
Liver International
|
| 2022-08 |
Co-administration of ursodeoxycholic acid with rosuvastatin/ezetimibe in a non-alcoholic fatty liver disease model |
Gastroenterology Report
|
| 2022-07 |
Prevalence and Risk Factors of Cardiovascular Disease in Patients with Chronic Hepatitis B |
Digestive Diseases and Sciences
|
| 2022-06 |
Anti-Cancer Effects of YAP Inhibitor (CA3) in Combination with Sorafenib against Hepatocellular Carcinoma (HCC) in Patient-Derived Multicellular Tumor Spheroid Models (MCTS) |
Cancers
|
| 2022-05 |
Probability of HBsAg loss after nucleo(s)tide analogue withdrawal depends on HBV genotype and viral antigen levels |
JOURNAL OF HEPATOLOGY
|
| 2022-05 |
Liver-Directed Concurrent Chemoradiotherapy versus Sorafenib in Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis |
Cancers
|
| 2022-04 |
KASL clinical practice guidelines for management of chronic hepatitis B |
Clinical and molecular hepatology
|
| 2022-04 |
Comparison of FibroScan-Aspartate Aminotransferase (FAST) Score and Other Non-invasive Surrogates in Predicting High-Risk Non-alcoholic Steatohepatitis Criteria |
Frontiers in Medicine
|
| 2022-04 |
Predictive Performance of CAGE-B and SAGE-B Models in Asian Treatment-Naive Patients Who Started Entecavir for Chronic Hepatitis B |
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY
|
| 2022-04 |
Prediction of Sustained Response After Nucleo(s)tide Analogue Cessation Using HBsAg and HBcrAg Levels: A Multicenter Study (CREATE) |
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY
|
| 2022-04 |
Long-term renal safety between patients with chronic hepatitis B receiving tenofovir vs. entecavir therapy: A multicenter study |
JOURNAL OF VIRAL HEPATITIS
|
| 2022-03 |
Fibrotic Burden Determines Cardiovascular Risk among Subjects with Metabolic Dysfunction-Associated Fatty Liver Disease |
Gut and Liver
|
| 2022-03 |
Cardiovascular Risk Is Elevated in Lean Subjects with Nonalcoholic Fatty Liver Disease |
GUT AND LIVER
|
| 2022-03 |
Impaired antibacterial response of liver sinusoidal Vγ9<sup>+</sup>Vδ 2<sup>+</sup>T cells in patients with chronic liver disease |
GUT
|
| 2022-02 |
Predictors of Sarcopenia in an Obese Asian Population |
NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL
|
| 2022-02 |
A micellized bone morphogenetic protein-7 prodrug ameliorates liver fibrosis by suppressing transforming growth factor- β signaling |
AMERICAN JOURNAL OF CANCER RESEARCH
|
| 2022-02 |
External Validation of the FSAC Model Using On-Therapy Changes in Noninvasive Fibrosis Markers in Patients with Chronic Hepatitis B: A Multicenter Study |
Cancers
|
| 2022-02 |
Validation of PH and Varices Risk Scores for Prediction of High-Risk Esophageal Varix and Bleeding in Patients with B-Viral Cirrhosis |
Diagnostics
|
| 2022-02 |
Episodic Detectable Viremia Does Not Affect Prognosis in Untreated Compensated Cirrhosis With Serum Hepatitis B Virus DNA ,2,000 IU/mL |
AMERICAN JOURNAL OF GASTROENTEROLOGY
|
| 2022-02 |
Increased prevalence rate of metabolic syndrome is an independent predictor of cardiovascular disease in patients with antineutrophil cytoplasmic antibody‑associated vasculitis |
RHEUMATOLOGY INTERNATIONAL
|
| 2022-01 |
Long-term effects of entecavir and tenofovir treatment on the fibrotic burden in patients with chronic hepatitis B |
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
|
| 2022-01 |
Transarterial Radioembolization for Unresectable Hepatocellular Carcinoma: Real-Life Efficacy and Safety Analysis of Korean Patients |
Cancers
|
| 2022-01 |
Regression of liver fibrosis and hepatocellular carcinoma development after HCV eradication with oral antiviral agents |
SCIENTIFIC REPORTS
|
| 2022-01 |
Validation of Pre-/Post-TACE-Predict Models among Patients with Hepatocellular Carcinoma Receiving Transarterial Chemoembolization |
Cancers
|
| 2021-12 |
Novel liver stiffness-based nomogram for predicting hepatocellular carcinoma risk in patients with chronic hepatitis B virus infection initiating antiviral therapy |
Cancers
|
| 2021-11 |
No influence of hepatic steatosis on the 3-year outcomes of patients with quiescent chronic hepatitis B |
JOURNAL OF VIRAL HEPATITIS
|
| 2021-11 |
YAP/TAZ Suppress Drug Penetration Into Hepatocellular Carcinoma Through Stromal Activation |
HEPATOLOGY
|
| 2021-10 |
Dickkopf-1 promotes angiogenesis by upregulating VEGF receptor 2-mediated mTOR/p70S6K signaling in hepatocellular carcinoma |
AMERICAN JOURNAL OF CANCER RESEARCH
|
| 2021-10 |
Risk stratification using sarcopenia status among subjects with metabolic dysfunction-associated fatty liver disease |
JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE
|
| 2021-10 |
Risk assessment of hepatocellular carcinoma and liver-related events using ultrasonography and transient elastography in patients with chronic hepatitis B |
JOURNAL OF VIRAL HEPATITIS
|
| 2021-10 |
Effect of tenofovir alafenamide vs. tenofovir disoproxil fumarate on hepatocellular carcinoma risk in chronic hepatitis B |
JOURNAL OF VIRAL HEPATITIS
|
| 2021-10 |
Impact of tenofovir alafenamide vs. entecavir on hepatocellular carcinoma risk in patients with chronic hepatitis B |
HEPATOLOGY INTERNATIONAL
|
| 2021-09 |
Screening, confirmation, and treatment rates of hepatitis C virus infection in a tertiary academic medical center in South Korea |
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
|
| 2021-09 |
Liver Stiffness-Based Risk Prediction Model for Hepatocellular Carcinoma in Patients with Nonalcoholic Fatty Liver Disease |
Cancers
|
| 2021-09 |
Hepatic Decompensation in Cirrhotic Patients Receiving Antiviral Therapy for Chronic Hepatitis B |
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY
|
| 2021-08 |
Controlled attenuation parameter value and the risk of hepatocellular carcinoma in chronic hepatitis B patients under antiviral therapy |
HEPATOLOGY INTERNATIONAL
|
| 2021-08 |
Besifovir dipivoxil maleate: a novel antiviral agent with low toxicity and high genetic barriers for chronic hepatitis B |
EXPERT OPINION ON PHARMACOTHERAPY
|
| 2021-07 |
The efficacies of entecavir and tenofovir in terms of enhancing prognosis after curative treatment of hepatitis B virus & ndash;related hepatocellular carcinoma |
EUROPEAN JOURNAL OF INTERNAL MEDICINE
|
| 2021-07 |
Pharmacokinetics and safety of evogliptin in hepatically impaired patients |
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
|
| 2021-07 |
Risk of hepatocellular carcinoma in patients with non-alcoholic fatty liver disease |
The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi
|
| 2021-07 |
Direct-Acting Antivirals Improve Treatment Outcomes in Patients with Hepatitis C Virus-Related Hepatocellular Carcinoma Treated with Transarterial Chemoembolization: A Nationwide, Multi-center, Retrospective Cohort Study |
DIGESTIVE DISEASES AND SCIENCES
|
| 2021-06 |
Association between the severity of liver fibrosis and cardiovascular outcomes in patients with type 2 diabetes |
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
|
| 2021-06 |
Dynamics of liver stiffness-based risk prediction model during antiviral therapy in patients with chronic hepatitis B |
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
|
| 2021-06 |
External validation of CAGE-B and SAGE-B scores for Asian chronic hepatitis B patients with well-controlled viremia by antivirals |
JOURNAL OF VIRAL HEPATITIS
|
| 2021-05 |
Lenvatinib is independently associated with the reduced risk of progressive disease when compared with sorafenib in patients with advanced hepatocellular carcinoma |
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
|
| 2021-05 |
Change in the Recurrence Pattern and Predictors over Time after Complete Cure of Hepatocellular Carcinoma |
GUT AND LIVER
|
| 2021-05 |
The Prognostic Role of On-Treatment Liver Stiffness for Hepatocellular Carcinoma Development in Patients with Chronic Hepatitis B |
Journal of Hepatocellular Carcinoma
|
| 2021-05 |
Empirical Treatment With Carbapenem vs Third-generation Cephalosporin for Treatment of Spontaneous Bacterial Peritonitis |
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY
|
| 2021-04 |
Treatment efficacy by hepatic arterial infusion chemotherapy vs. sorafenib after liver-directed concurrent chemoradiotherapy for advanced hepatocellular carcinoma |
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
|
| 2021-04 |
Revised Korean Antiviral Guideline Reduces the Hepatitis B-related Hepatocellular Carcinoma Risk in Cirrhotic Patients |
JOURNAL OF KOREAN MEDICAL SCIENCE
|
| 2021-04 |
Negligible risks of hepatocellular carcinoma during biomarker-defined immune-tolerant phase for patients with chronic hepatitis B |
Clinical and molecular hepatology
|
| 2021-04 |
Impact of antiviral therapy on risk prediction model for hepatocellular carcinoma development in patients with chronic hepatitis B |
HEPATOLOGY RESEARCH
|
| 2021-03 |
A Case of Lymphocyte-Rich Hepatocellular Carcinoma in a Patient Who Was Treated for Colon Cancer |
Journal of liver cancer (대한간암학회지)
|
| 2021-03 |
Association Between Curative Treatment after Transarterial Radioembolization and Better Survival Outcomes in Patients with Hepatocellular Carcinoma |
CANCER INVESTIGATION
|
| 2021-02 |
Predictors of Complete Response in Patients with Hepatocellular Carcinoma Treated with Trans-Arterial Radioembolization |
Current Oncology
|
| 2021-01 |
Evolution of liver fibrosis and steatosis markers in patients with type 2 diabetes after metformin treatment for 2 years |
JOURNAL OF DIABETES AND ITS COMPLICATIONS
|
| 2021-01 |
Risk and Risk Score Performance of Hepatocellular Carcinoma Development in Patients With Hepatitis B Surface Antigen Seroclearance |
Clinical and Translational Gastroenterology
|
| 2021-01 |
Hepatic Steatosis Index in the Detection of Fatty Liver in Patients with Chronic Hepatitis B Receiving Antiviral Therapy |
GUT AND LIVER
|
| 2021-01 |
Prognostic Value of Alpha-Fetoprotein in Patients Who Achieve a Complete Response to Transarterial Chemoembolization for Hepatocellular Carcinoma |
YONSEI MEDICAL JOURNAL
|
| 2021-01 |
Validation of risk prediction scores for hepatocellular carcinoma in patients with chronic hepatitis B treated with entecavir or tenofovir |
JOURNAL OF VIRAL HEPATITIS
|
| 2020-12 |
A multi-centre study of trends in hepatitis B virus-related hepatocellular carcinoma risk over time during long-term entecavir therapy |
JOURNAL OF VIRAL HEPATITIS
|
| 2020-12 |
Genetic risk factors associated with NAFLD |
Hepatoma Research
|
| 2020-12 |
Efficacy of Lenvervimab, a Recombinant Human Immunoglobulin, in Treatment of Chronic Hepatitis B Virus Infection |
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY
|
| 2020-12 |
Appraisal of Long-Term Outcomes of Liver-Directed Concurrent Chemoradiotherapy for Hepatocellular Carcinoma with Major Portal Vein Invasion |
Journal of hepatocellular carcinoma
|
| 2020-12 |
Combined use of rosuvastatin and ezetimibe improves hepatic steatosis in patients with dyslipidemia |
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
|
| 2020-12 |
Tenofovir-based combination therapy or monotherapy for multidrug-resistant chronic hepatitis B: Long-term data from a multicenter cohort study |
JOURNAL OF VIRAL HEPATITIS
|
| 2020-11 |
Correlation of the grade of hepatic steatosis between controlled attenuation parameter and ultrasound in patients with fatty liver: a multi-center retrospective cohort study |
KOREAN JOURNAL OF INTERNAL MEDICINE
|
| 2020-11 |
The Modified Response Evaluation Criteria in Solid Tumors (RECIST) Yield a More Accurate Prognoses Than the RECIST 1.1 in Hepatocellular Carcinoma Treated with Transarterial Radioembolization |
GUT AND LIVER
|
| 2020-11 |
Hepatocellular Carcinoma Risk According to Regimens for Eradication of Hepatitis C Virus; Interferon or Direct Acting Antivirals |
Cancers
|
| 2020-11 |
High body mass index hinders fibrosis improvement in patients receiving long-term tenofovir therapy in hepatitis B virus-related cirrhosis |
JOURNAL OF VIRAL HEPATITIS
|
| 2020-11 |
Association between liver fibrosis and appendicular skeletal muscle mass during antiviral therapy in chronic hepatitis B |
DIGESTIVE AND LIVER DISEASE
|
| 2020-10 |
Comparison of clinical practice guidelines for the management of chronic hepatitis B: When to start, when to change, and when to stop |
Clinical and molecular hepatology
|
| 2020-09 |
Advanced Liver Fibrosis Predicts Unfavorable Long-Term Prognosis in First-Ever Ischemic Stroke or Transient Ischemic Attack |
CEREBROVASCULAR DISEASES
|
| 2020-09 |
Hepatocellular Carcinoma in Korea between 2012 and 2014: an Analysis of Data from the Korean Nationwide Cancer Registry |
Journal of liver cancer (대한간암학회지)
|